NOVOLAB: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
NOVOLAB
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€180,635
2024 · €424,944-€244,309
Equity
€2.1m
2024 · €1.9m+€180,635
Cash
€1.2m
2024 · €1.6m-€405,368
Balance sheet total
€3.4m
2024 · €3.8m-€440,333
Largest movements
Assets
- Cash -€405,368
down €405,368 (-24.9%), from €1.6m to €1.2m
mainly Other debts (-€500,095) and Current portion of long-term debt (-€116,316)
- Receivables within one year -€161,985
down €161,985 (-13.0%), from €1.2m to €1.1m
of which Trade receivables: -€192,595
- Stocks and contracts +€108,744
up €108,744 (+13.7%), from €795,631 to €904,375
Equity and liabilities
- Other debts -€500,095
down €500,095 (-45.3%), from €1.1m to €604,936
- Profit (loss) carried forward +€180,635
up €180,635 (+12.9%), from €1.4m to €1.6m
- Current portion of long-term debt -€116,316
down €116,316 (-88.1%), from €132,005 to €15,689
Income statement
- Turnover +€6.5m
new in 2025: €6.5m
- Purchases and services +€5.3m
new in 2025: €5.3m
- Gross operating margin -€172,318
down €172,318 (-12.3%), from €1.4m to €1.2m
- Staff costs +€142,733
up €142,733 (+17.4%), from €819,267 to €962,000
- Taxes -€82,191
down €82,191 (-55.1%), from €149,293 to €67,102
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€424,944
Gross operating margin
-€172,318
Staff costs
-€142,733
Depreciation
+€15,169
Provisions
-€23,400
Other operating charges
+€403
Financial income
-€7,325
Financial charges
+€3,704
Taxes
+€82,191
Result 2025
€180,635
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
-€247,953
Investment
-€25,288
Financing
-€132,127
Cash 2024
€1.6m
From operations (derived)
-€247,953
Net result for the year
+€180,635
Depreciation
+€2,910
Stocks and contracts
-€108,744
Receivables within one year
+€161,985
Deferred charges and accrued income
+€4,102
Trade debts
-€8,707
Tax, wage and social debts
+€19,961
Other debts
-€500,095
Investment (derived)
-€25,288
Investment in fixed assets (net)
-€25,288
Financing
-€132,127
Debts after one year
-€15,689
Current portion of long-term debt
-€116,316
Short-term financial debts
-€122
Cash 2025
€1.2m
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,809,016 | €3,368,683 | -€440,333 | -11.6% |
| Fixed assets | 21/28 | €138,141 | €160,519 | +€22,378 | +16.2% |
| Tangible fixed assets | 22/27 | €129,621 | €151,999 | +€22,378 | +17.3% |
| Land and buildings | 22 | €128,074 | €151,999 | +€23,925 | +18.7% |
| Furniture and vehicles | 24 | €1,547 | - | -€1,547 | |
| Financial fixed assets | 28 | €8,520 | €8,520 | = | 0.0% |
| Current assets | 29/58 | €3,670,875 | €3,208,164 | -€462,711 | -12.6% |
| Stocks and contracts in progress | 3 | €795,631 | €904,375 | +€108,744 | +13.7% |
| Stocks | 30/36 | €795,631 | €904,375 | +€108,744 | +13.7% |
| Amounts receivable within one year | 40/41 | €1,243,249 | €1,081,264 | -€161,985 | -13.0% |
| Trade receivables | 40 | €1,221,126 | €1,028,531 | -€192,595 | -15.8% |
| Other amounts receivable | 41 | €22,123 | €52,733 | +€30,610 | +138% |
| Cash at bank and in hand | 54/58 | €1,627,383 | €1,222,015 | -€405,368 | -24.9% |
| Deferred charges and accrued income | 490/1 | €4,612 | €510 | -€4,102 | -88.9% |
| Total equity and liabilities | 10/49 | €3,809,016 | €3,368,683 | -€440,333 | -11.6% |
| Equity | 10/15 | €1,881,237 | €2,061,872 | +€180,635 | +9.6% |
| Contributions | 10/11 | €67,000 | €67,000 | = | 0.0% |
| Capital | 10 | €67,000 | €67,000 | = | 0.0% |
| Issued capital | 100 | €67,000 | €67,000 | = | 0.0% |
| Reserves | 13 | €406,700 | €406,700 | = | 0.0% |
| Non-distributable reserves | 130/1 | €6,700 | €6,700 | = | 0.0% |
| Legal reserve | 130 | €6,700 | €6,700 | = | 0.0% |
| Distributable reserves | 133 | €400,000 | €400,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,405,250 | €1,585,885 | +€180,635 | +12.9% |
| Investment grants | 15 | €2,287 | €2,287 | = | 0.0% |
| Provisions and deferred taxes | 16 | €1,535 | €1,535 | = | 0.0% |
| Deferred taxes | 168 | €1,535 | €1,535 | = | 0.0% |
| Amounts payable | 17/49 | €1,926,244 | €1,305,276 | -€620,968 | -32.2% |
| Amounts payable after more than one year | 17 | €15,689 | - | -€15,689 | |
| Financial debts | 170/4 | €15,689 | - | -€15,689 | |
| Amounts payable within one year | 42/48 | €1,905,555 | €1,300,276 | -€605,279 | -31.8% |
| Current portion of amounts payable after more than one year | 42 | €132,005 | €15,689 | -€116,316 | -88.1% |
| Financial debts | 43 | €41,213 | €41,091 | -€122 | -0.3% |
| Credit institutions | 430/8 | €41,213 | €41,091 | -€122 | -0.3% |
| Trade debts | 44 | €442,490 | €433,783 | -€8,707 | -2.0% |
| Suppliers | 440/4 | €442,490 | €433,783 | -€8,707 | -2.0% |
| Taxes, remuneration and social security | 45 | €184,816 | €204,777 | +€19,961 | +10.8% |
| Taxes | 450/3 | €70,373 | €66,936 | -€3,437 | -4.9% |
| Remuneration and social security | 454/9 | €114,443 | €137,841 | +€23,398 | +20.4% |
| Other amounts payable | 47/48 | €1,105,031 | €604,936 | -€500,095 | -45.3% |
| Accrued charges and deferred income | 492/3 | €5,000 | €5,000 | = | 0.0% |
| Turnover | 70 | - | €6,515,756 | +€6.5m | |
| Goods, raw materials, services and sundry goods | 60/61 | - | €5,284,925 | +€5.3m | |
| Remuneration, social security and pensions | 62 | €819,267 | €962,000 | +€142,733 | +17.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €18,079 | €2,910 | -€15,169 | -83.9% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | -€23,400 | - | +€23,400 | |
| Other operating charges | 640/8 | €17,266 | €16,863 | -€403 | -2.3% |
| Gross operating margin | 9900 | €1,403,150 | €1,230,832 | -€172,318 | -12.3% |
| Operating profit (loss) | 9901 | €571,938 | €249,059 | -€322,879 | -56.5% |
| Financial income | 75/76B | €21,050 | €13,725 | -€7,325 | -34.8% |
| Recurring financial income | 75 | €21,050 | €13,725 | -€7,325 | -34.8% |
| Financial charges | 65/66B | €18,751 | €15,047 | -€3,704 | -19.8% |
| Recurring financial charges | 65 | €18,751 | €15,047 | -€3,704 | -19.8% |
| Profit (loss) for the period before taxes | 9903 | €574,237 | €247,737 | -€326,500 | -56.9% |
| Income taxes | 67/77 | €149,293 | €67,102 | -€82,191 | -55.1% |
| Profit (loss) for the period | 9904 | €424,944 | €180,635 | -€244,309 | -57.5% |
| Profit (loss) for the period to be appropriated | 9905 | €424,944 | €180,635 | -€244,309 | -57.5% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.